Lara Longpre - CHIEF DEVELOPMENT OFFICER at Mirum Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Stock Symbol
MIRM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Lara Longpre - trading volume in the past year for Mirum Pharmaceuticals, Inc.

Holdings reported by Lara Longpre for Mirum Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 104K $2.73M $26.19 Feb 2, 2024 Direct
Restricted Stock Units 8K $224K $28.04 Jan 23, 2024 Direct Common Stock
Stock Option (right to buy) 32K Jan 23, 2024 Direct Common Stock

Transactions reported by Lara Longpre for Mirum Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.